Skip to content
Unrated Drug recall · FDA · Published August 17, 2023

Lundbeck Sabril Oral Solution Recall: Cross Contamination Risk

Lundbeck recalls Sabril oral solution (500mg, 50 packets) due to cross contamination with other products. Affected lots manufactured in Cincinnati, OH. No remedy specified in recall notice.

🇺🇸 FDA recall #D-1142-2023DrugLundbeck ›
Take action

Contact the company

Recalling firmLundbeck LLC6 Parkway North Blvd Ste 400 · Deerfield, IL 60015-2522
✎ GovInfoNow plain-language explainer

Lundbeck is recalling Sabril oral solution (500mg, 50 packets) because it may have been cross contaminated with other products. This could affect people taking this medication for seizures. The recall does not include a remedy. Read more at govinfonow.com/recall/33181-lundbeck-sabril-oral-solution-recall-cross-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/33181-lundbeck-sabril-oral-solution-recall-cross-contamination-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-1142-2023

Cite this page

“Lundbeck Sabril Oral Solution Recall: Cross Contamination Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/33181-lundbeck-sabril-oral-solution-recall-cross-contamination-risk. Based on FDA recall #D-1142-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1142-2023%22&limit=1).

Lundbeck LLC voluntarily recalled Sabril (vigabatrin) for Oral Solution due to cross-contamination with other products, the Food and Drug Administration said on Aug. 17, 2023. The agency issued recall number D-1142-2023 for the Class III drug.

How to tell if you have it

  • Brand: Lundbeck
  • Product: Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets
  • NDC: 67386-211-65
  • Lot codes: 3207333A, 3207334A (Exp 03/2027); 3214707A, 3214709A, 3214710A (Exp 02/2028)
  • Manufacturer: Patheon, Cincinnati, OH
  • Quantity: 10,543 cartons

The hazard

The recall addresses cross-contamination with other products. The FDA classified the recall as Class III.

Context

GovInfoNow's records show Glenmark issued a Nebivolol Tablets Recall on Nov. 18, 2025, citing a cross-contamination hazard. Lannett recalled Primidone Tablets on April 24, 2026, due to a cross-contamination risk. Amerisource Health also recalled Primidone Tablets on May 1, 2026, for a similar cross-contamination risk.

How to tell if you have this one

Check the product label for Sabril (vigabatrin) oral solution, 500 mg, 50 packets. Look for lot numbers 3207333A, 3207334A (expiring 03/2027) or 3214707A, 3214709A, 3214710A (expiring 02/2028).

  • Brand
    Lundbeck
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the lot numbers 3207333A, 3207334A (expiring 03/2027) or 3214707A, 3214709A, 3214710A (expiring 02/2028) on the Sabril oral solution packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 20 days after the firm started it.

1. Firm started the recall: Aug 17, 202312. FDA classified it Class III: Aug 29, 202323. Published in FDA’s Enforcement Report: Sep 6, 202332023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1142-2023 (August 17, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1142-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA